Minot DeBlois Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40.1K Buy
333
+233
+233% +$26.9K 0.04% 115
2025
Q4
$10.6K Sell
100
-318
-76% -$29.9K 0.01% 123
2025
Q3
$35.1K Sell
418
-25
-6% -$2.06K 0.03% 115
2025
Q2
$35.1K Hold
443
0.03% 120
2025
Q1
$39.8K Sell
443
-5
-1% -$467 0.04% 114
2024
Q4
$44.6K Buy
+448
New +$46.2K 0.04% 126

Other funds holding MRK

Minot DeBlois Advisors's MRK Position: Q1 2026 in Review

Minot DeBlois Advisors increased its Merck (MRK) stake by 233% in Q1 2026, buying an estimated $26.9K and bringing the position to 333 shares worth $40.1K. The position accounts for 0.04% of the portfolio, ranked #115.

Minot DeBlois Advisors first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. The position peaked at $44.6K in Q4 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Minot DeBlois Advisors held 333 shares of Merck worth $40.1K as of Q1 2026.
  • Minot DeBlois Advisors bought 233 Merck shares in Q1 2026, an estimated $26.9K.
  • Merck made up 0.04% of Minot DeBlois Advisors's portfolio in Q1 2026, its #115 holding.
  • Minot DeBlois Advisors first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • Minot DeBlois Advisors's Merck position peaked at $44.6K in Q4 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Minot DeBlois Advisors's 13F filing for Q1 2026, filed 8 May 2026.